GlassScriptPhysician profile
Shahla M Powell
NPI 1487141743
$1,516.95
in general payments reported to CMS, 2019-2025
15 companies · $434 in 2025
The $434 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $42.81 · 2023: $306 · 2024: $735 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,404 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,404.15 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $262.79 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $244.83 | 2023-2025 | Slynd |
| Astellas Pharma US INC | $217.03 | 2023-2025 | Veozah |
| Abbvie INC. | $174.82 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $172.41 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $85.53 | 2023-2025 | Gardasil 9, Gardasil |
| Evofem Biosciences, INC. | $69.83 | 2023-2024 | Phexxi |
| Organon LLC | $67.60 | 2023-2024 | Nexplanon |
| Millicent US INC | $58.66 | 2024-2025 | Intrarosa |
| Pfizer INC. | $43.27 | 2023-2024 | |
| Hologic Sales and Service, LLC | $35.15 | 2024-2025 | Aptima |
| Exact Sciences Corporation | $26.97 | 2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $23.06 | 2025 | |
| Agile Therapeutics, INC. | $21.43 | 2023 | Twirla |
| Sumitomo Pharma America, INC. | $13.57 | 2025 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shahla Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.